Efficacy and Safety of Idelalisib in Combination With Obinutuzumab Compared to Chlorambucil in Combination With Obinutuzumab for Previously Untreated Chronic Lymphocytic Leukemia
- Status
- TERMINATED
- Phase
- PHASE3
Clinical Trials Related to Chronic Lymphocytic Leukemia
Related studies linked through entity extraction aliases.
A Study of PCI-32765 (Ibrutinib) Versus Rituximab in Relapsed or Refractory Chronic Leukemia/Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases
- Status
- TERMINATED
- Phase
- NA
Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD Prevention
- Status
- COMPLETED
- Phase
- PHASE3
Phase II Study of Vismodegib in Patients With Refractory or Relapsed B-cell Lymphoma or Chronic Lymphocytic Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
Safety and Tolerability of HSC835 in Patients With Hematological Malignancies Undergoing Single Umbilical Cord Blood Transplant
- Status
- COMPLETED
- Phase
- PHASE2
A Safety and Efficacy Study of Obinutuzumab Alone or in Combination With Chemotherapy in Participants With Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
Pneumococcal Vaccine in Untreated CLL Patients
- Status
- COMPLETED
- Phase
- PHASE3
The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
- Status
- RECRUITING
- Phase
- N/A
A Study of the Efficacy of ABT-199 in Subjects With Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia With the 17p Deletion
- Status
- COMPLETED
- Phase
- PHASE2
Study of IPI-145 in Combination With Rituximab or Bendamustine/Rituximab in Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- Status
- RECRUITING
- Phase
- PHASE1
Eradication of Residual Disease by Preemptive Immunointervention After Allogeneic Hematopoietic Stem Cells Transplantation in Chronic Lymphocytic Leukemia
- Status
- UNKNOWN
- Phase
- PHASE2
Rapid Infusion of Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 1 Study of Novel GS-9973 Tablet Formulations to Evaluate the Effect of Acid Reducing Agents, Relative Bioavailability, and Food Effect on GS-9973 Pharmacokinetics
- Status
- COMPLETED
- Phase
- PHASE1
BR in Patients With CLL With Comorbidities and/or Renal Dysfunction
- Status
- COMPLETED
- Phase
- PHASE1
A Long-term Extension Study of PCI-32765 (Ibrutinib)
- Status
- RECRUITING
- Phase
- PHASE3
Study to Evaluate Efficacy, Safety, Tolerability, and Pharmacodynamics of Entospletinib in Adults With Relapsed or Refractory Hematologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE2
Entospletinib in Combination With Idelalisib in Adults With Relapsed or Refractory Hematologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE2